# OnCo record cassiopeia (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/cassiopeia/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "cassiopeia", "NCT02541383" ;
  schema:name "CASSIOPEIA"@en ;
  schema:description "CASSIOPEIA showed that adding the CD38 antibody daratumumab to a three-drug induction before stem cell transplant put more people with myeloma into deep remission and kept the disease away for longer."@en ;
  schema:url <https://onco.cc/trials/cassiopeia/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02541383> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/myeloma-transplant-eligible/>, <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:drugs <https://onco.cc/drugs/daratumumab/>, <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/thalidomide/>, <https://onco.cc/drugs/dexamethasone/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> ;
  onco:people <https://onco.cc/people/philippe-moreau/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-cassiopeia-lancet-2019/> .